Q1 2024 · 13F-HR
ADAR1 Capital Management, LLCholdings as filed
Filed 2024-05-15 · accession 0001940272-24-000003
$440.8M
Reported value
261
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $35.0M | 7.95% | 234,400 | PUT | SOLE |
| 02072L565 | BOXX | EA SERIES TRUST | $33.9M | 7.68% | 318,120 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $29.4M | 6.68% | 2,791,870 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $27.2M | 6.17% | 52,000 | PUT | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $26.9M | 6.11% | 180,145 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $22.7M | 5.16% | 785,655 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $22.4M | 5.08% | 319,510 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $22.4M | 5.08% | 338,243 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $21.9M | 4.97% | 721,301 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $17.0M | 3.86% | 549,804 | Common | SOLE |
| 590328209 | MACKEUR | MERRIMACK PHARMACEUTICALS IN | $13.3M | 3.02% | 902,350 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $7.3M | 1.67% | 48,584 | Common | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $5.4M | 1.21% | 2,074,183 | Common | SOLE |
| 05455M100 | — | AVROBIO INC | $5.1M | 1.15% | 3,954,857 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $4.9M | 1.12% | 31,505 | Common | SOLE |
| 46090E103 | QQQ | INVESCO QQQ TR | $4.4M | 1.01% | 10,000 | PUT | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $4.2M | 0.96% | 156,600 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $4.2M | 0.95% | 403,500 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $4.0M | 0.91% | 31,105 | Common | SOLE |
| 29260Y109 | 0C3 | ENDEAVOR GROUP HLDGS INC | $4.0M | 0.91% | 155,250 | Common | SOLE |
| 004468500 | ACHV | ACHIEVE LIFE SCIENCES INC | $4.0M | 0.90% | 875,000 | Common | SOLE |
| 36118A100 | — | FUSION PHARMACEUTICALS INC | $3.8M | 0.86% | 177,200 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $3.3M | 0.76% | 586,984 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $3.3M | 0.75% | 180,911 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $3.2M | 0.73% | 339,825 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $3.2M | 0.73% | 187,567 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $3.1M | 0.70% | 456,588 | Common | SOLE |
| 78468R663 | BIL | SPDR SER TR | $3.0M | 0.68% | 32,500 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $3.0M | 0.67% | 106,342 | Common | SOLE |
| 92203C303 | VUSB | VANGUARD BD INDEX FDS | $2.7M | 0.62% | 55,206 | Common | SOLE |
| 46641Q837 | JPST | J P MORGAN EXCHANGE TRADED F | $2.7M | 0.62% | 54,000 | Common | SOLE |
| 464288679 | SHV | ISHARES TR | $2.7M | 0.61% | 24,500 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $2.7M | 0.61% | 203,204 | Common | SOLE |
| 97717Y527 | USFR | WISDOMTREE TR | $2.7M | 0.60% | 53,000 | Common | SOLE |
| 15117F807 | CLRBUSD | CELLECTAR BIOSCIENCES INC | $2.6M | 0.58% | 642,541 | Common | SOLE |
| 68218J103 | OABI | OMNIAB INC | $2.4M | 0.56% | 451,485 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $2.3M | 0.53% | 206,856 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $2.2M | 0.50% | 2,300 | Common | SOLE |
| 451033708 | IBIO | IBIO INC | $2.2M | 0.50% | 600,000 | Common | SOLE |
| 22052L104 | CTVA | CORTEVA INC | $2.2M | 0.49% | 37,400 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $2.1M | 0.48% | 50,200 | PUT | SOLE |
| 08862L103 | — | BEYOND AIR INC | $2.1M | 0.48% | 1,204,820 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $2.1M | 0.47% | 100,000 | CALL | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $2.0M | 0.45% | 60,763 | Common | SOLE |
| 53220K504 | LGND | LIGAND PHARMACEUTICALS INC | $2.0M | 0.44% | 26,800 | Common | SOLE |
| 78467V707 | ULST | SSGA ACTIVE ETF TR | $1.9M | 0.44% | 47,684 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $1.9M | 0.43% | 49,500 | Common | SOLE |
| 80810D103 | SDGR | SCHRODINGER INC | $1.7M | 0.39% | 63,586 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $1.7M | 0.38% | 11,200 | CALL | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $1.6M | 0.36% | 926,929 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.5M | 0.35% | 292,850 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $1.5M | 0.34% | 25,700 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $1.5M | 0.33% | 1,865 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $1.4M | 0.33% | 101,626 | Common | SOLE |
| 62921N105 | NGMUSD | NGM BIOPHARMACEUTICALS INC | $1.3M | 0.29% | 816,581 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $1.2M | 0.27% | 14,401 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $1.2M | 0.27% | 59,700 | Common | SOLE |
| 29415J106 | — | ENVVENO MEDICAL CORPORATION | $1.1M | 0.25% | 201,728 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $1.1M | 0.25% | 26,200 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $1.0M | 0.24% | 218,973 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $1.0M | 0.23% | 24,259 | Common | SOLE |
| 03475V101 | ANGO | ANGIODYNAMICS INC | $900,235 | 0.20% | 153,362 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $865,944 | 0.20% | 40,090 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $864,501 | 0.20% | 732,628 | Common | SOLE |
| 37962G102 | — | GLOBAL STAR ACQUISITION INC | $856,800 | 0.19% | 80,000 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $852,182 | 0.19% | 91,534 | Common | SOLE |
| 46489V104 | ISREUR | PERSPECTIVE THERAPEUTICS INC | $805,303 | 0.18% | 676,725 | Common | SOLE |
| G52443101 | KVACU | KEEN VISION ACQUISITION CORP | $788,250 | 0.18% | 75,000 | Common | SOLE |
| 00507W206 | ATNM | ACTINIUM PHARMACEUTICALS INC | $783,000 | 0.18% | 100,000 | Common | SOLE |
| 49721T309 | EYEGEUR | KIORA PHARMACEUTICALS INC | $776,600 | 0.18% | 1,100,000 | Common | SOLE |
| 00430K865 | — | ACASTI PHARMA INC | $744,530 | 0.17% | 217,381 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $693,475 | 0.16% | 19,701 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $643,200 | 0.15% | 16,000 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $627,840 | 0.14% | 16,000 | Common | SOLE |
| 88338N206 | TXMD | THERAPEUTICSMD INC | $623,246 | 0.14% | 272,160 | Common | SOLE |
| 955306105 | WST | WEST PHARMACEUTICAL SVSC INC | $593,565 | 0.13% | 1,500 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $591,213 | 0.13% | 27,601 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $537,292 | 0.12% | 12,400 | Common | SOLE |
| G89229119 | — | TMT ACQUISITION CORP | $534,500 | 0.12% | 50,000 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $527,100 | 0.12% | 14,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $523,438 | 0.12% | 35,608 | Common | SOLE |
| 00039J103 | YEAR | AB ACTIVE ETFS INC | $505,200 | 0.11% | 10,000 | Common | SOLE |
| T9224W109 | STVN | STEVANATO GROUP S P A | $497,550 | 0.11% | 15,500 | Common | SOLE |
| 69344A107 | PULS | PGIM ETF TR | $497,000 | 0.11% | 10,000 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $474,873 | 0.11% | 89,938 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $470,163 | 0.11% | 15,900 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $464,120 | 0.11% | 28,300 | Common | SOLE |
| G31659108 | — | ARYA SCIENCES ACQU CORP IV | $459,644 | 0.10% | 40,930 | Common | SOLE |
| 29446K106 | EQ | EQUILLIUM INC | $459,170 | 0.10% | 198,775 | Common | SOLE |
| 36151G600 | GBS1EUR | INTELLIGENT BIO SOLUTIONS IN | $456,815 | 0.10% | 108,250 | Common | SOLE |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $417,300 | 0.09% | 139,100 | PUT | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $398,700 | 0.09% | 6,000 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $362,403 | 0.08% | 202,460 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $359,307 | 0.08% | 14,430 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $352,440 | 0.08% | 22,000 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $350,710 | 0.08% | 17,000 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $337,979 | 0.08% | 110,091 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $337,900 | 0.08% | 155,000 | Common | SOLE |
| 67190B104 | OAKU | OAK WOODS ACQUISITION CORP | $322,500 | 0.07% | 30,000 | Common | SOLE |
| G79407105 | — | SCREAMING EAGLE ACQUISITN CO | $321,000 | 0.07% | 30,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $316,050 | 0.07% | 52,500 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $309,840 | 0.07% | 24,000 | Common | SOLE |
| G5212E139 | — | JVSPAC ACQUISITION CORP | $309,000 | 0.07% | 30,000 | Common | SOLE |
| 02079K305 | GOOGL | ALPHABET INC | $301,860 | 0.07% | 2,000 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $287,023 | 0.07% | 365,216 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $284,189 | 0.06% | 205,934 | Common | SOLE |
| 25400Q105 | DJT | TRUMP MEDIA & TECHNOLOGY GRO | $278,820 | 0.06% | 4,500 | CALL | SOLE |
| 80105N105 | SNY | SANOFI | $267,300 | 0.06% | 5,500 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $264,724 | 0.06% | 11,560 | Common | SOLE |
| 19239V302 | CCOI | COGENT COMMUNICATIONS HLDGS | $261,320 | 0.06% | 4,000 | Common | SOLE |
| 462837204 | — | IRON HORSE ACQUISITIONS CORP | $254,750 | 0.06% | 25,000 | Common | SOLE |
| 72201R882 | ZROZ | PIMCO ETF TR | $237,750 | 0.05% | 3,000 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $235,284 | 0.05% | 336,072 | Common | SOLE |
| 68404L201 | OPCH | OPTION CARE HEALTH INC | $234,780 | 0.05% | 7,000 | Common | SOLE |
| 015857105 | AQN | ALGONQUIN PWR UTILS CORP | $233,840 | 0.05% | 37,000 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $214,500 | 0.05% | 15,000 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $213,339 | 0.05% | 236,623 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $210,444 | 0.05% | 74,100 | CALL | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $204,680 | 0.05% | 30,100 | PUT | SOLE |
| 70261F202 | KTTA | PASITHEA THERAPEUTICS CORP | $200,804 | 0.05% | 27,696 | Common | SOLE |
| 464287432 | TLT | ISHARES TR | $189,240 | 0.04% | 2,000 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $185,100 | 0.04% | 30,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $175,275 | 0.04% | 2,500 | CALL | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $170,262 | 0.04% | 16,200 | Common | SOLE |
| G4095J109 | GLRE | GREENLIGHT CAPITAL RE LTD | $166,911 | 0.04% | 13,385 | Common | SOLE |
| 31561T102 | AIEV | FEUTUNE LIGHT ACQUISITION CO | $163,050 | 0.04% | 15,000 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $159,124 | 0.04% | 1,400 | Common | SOLE |
| 67079A102 | — | NUVEI CORPORATION | $158,100 | 0.04% | 5,000 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $155,352 | 0.04% | 1,200 | CALL | SOLE |
| G1148A127 | BKHAU | BLACK HAWK ACQUISITION CORP | $152,250 | 0.03% | 15,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $151,834 | 0.03% | 8,900 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $150,690 | 0.03% | 3,000 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $148,323 | 0.03% | 5,988 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $136,620 | 0.03% | 2,000 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $134,212 | 0.03% | 250 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $134,135 | 0.03% | 12,583 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $130,500 | 0.03% | 6,000 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $125,715 | 0.03% | 2,900 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $124,845 | 0.03% | 43,500 | Common | SOLE |
| 34962G109 | TOCAEUR | FORTE BIOSCIENCES INC | $118,709 | 0.03% | 170,510 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $118,600 | 0.03% | 10,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $117,402 | 0.03% | 1,700 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $112,800 | 0.03% | 6,000 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $110,357 | 0.03% | 38,858 | Common | SOLE |
| 47215P106 | JD | JD.COM INC | $109,560 | 0.02% | 4,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $109,380 | 0.02% | 2,000 | CALL | SOLE |
| 35088F107 | FORL | FOUR LEAF ACQUISITION CORP | $107,200 | 0.02% | 10,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $107,150 | 0.02% | 2,500 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $101,392 | 0.02% | 15,021 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $98,928 | 0.02% | 4,580 | Common | SOLE |
| G5251K103 | — | KENSINGTON CAPITAL ACQUISITI | $97,560 | 0.02% | 9,000 | Common | SOLE |
| 52886N406 | LEXX | LEXARIA BIOSCIENCE CORP | $96,652 | 0.02% | 26,626 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $95,921 | 0.02% | 43,014 | Common | SOLE |
| 071705107 | BLCO | BAUSCH PLUS LOMB CORP | $91,690 | 0.02% | 5,300 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $90,312 | 0.02% | 31,800 | PUT | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $89,995 | 0.02% | 2,050 | Common | SOLE |
| 02209S103 | MO | ALTRIA GROUP INC | $87,240 | 0.02% | 2,000 | Common | SOLE |
| 606710200 | MITK | MITEK SYS INC | $78,960 | 0.02% | 5,600 | Common | SOLE |
| 65445K200 | — | 99 ACQUISITION GROUP INC | $78,675 | 0.02% | 7,500 | Common | SOLE |
| G01490138 | — | AI TRANSN ACQUISITION CORP | $78,150 | 0.02% | 7,500 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $74,100 | 0.02% | 5,000 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $73,388 | 0.02% | 31,229 | Common | SOLE |
| 44267T102 | HHH | HOWARD HUGHES HOLDINGS INC | $72,620 | 0.02% | 1,000 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $70,640 | 0.02% | 2,406 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $67,350 | 0.02% | 7,500 | PUT | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $66,331 | 0.02% | 4,361 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $65,477 | 0.01% | 4,652 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $63,720 | 0.01% | 2,000 | Common | SOLE |
| 071734107 | BHC | BAUSCH HEALTH COS INC | $63,660 | 0.01% | 6,000 | CALL | SOLE |
| 92189F106 | GDX | VANECK ETF TRUST | $63,240 | 0.01% | 2,000 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $62,240 | 0.01% | 1,000 | Common | SOLE |
| 30050E105 | EVO | EVOTEC AG | $60,291 | 0.01% | 7,700 | Common | SOLE |
| 500255104 | KSS | KOHLS CORP | $58,300 | 0.01% | 2,000 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $55,785 | 0.01% | 896 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $53,379 | 0.01% | 300 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $52,675 | 0.01% | 2,500 | Common | SOLE |
| 500767306 | KWEB | KRANESHARES TRUST | $52,500 | 0.01% | 2,000 | Common | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $50,172 | 0.01% | 21,350 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $50,160 | 0.01% | 16,446 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $49,700 | 0.01% | 35,000 | Common | SOLE |
| 03212B103 | AMPY | AMPLIFY ENERGY CORP NEW | $46,805 | 0.01% | 7,081 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $46,220 | 0.01% | 2,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $46,121 | 0.01% | 1,700 | PUT | SOLE |
| 90385V107 | UCTT | ULTRA CLEAN HLDGS INC | $45,940 | 0.01% | 1,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $45,645 | 0.01% | 1,807 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $45,040 | 0.01% | 2,000 | CALL | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $44,650 | 0.01% | 2,550 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $44,267 | 0.01% | 8,629 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $42,600 | 0.01% | 10,000 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $42,157 | 0.01% | 4,254 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $41,040 | 0.01% | 2,000 | Common | SOLE |
| 00773U207 | AVU0 | ADVERUM BIOTECHNOLOGIES INC | $39,592 | 0.01% | 2,800 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $39,585 | 0.01% | 300 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $39,150 | 0.01% | 2,900 | Common | SOLE |
| 55933J203 | MX | MAGNACHIP SEMICONDUCTOR CORP | $39,060 | 0.01% | 7,000 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $38,600 | 0.01% | 4,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $37,104 | 0.01% | 1,200 | PUT | SOLE |
| 04522R200 | — | ASLAN PHARMACEUTICALS LTD | $36,539 | 0.01% | 59,393 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $35,618 | 0.01% | 3,060 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA PHARMA INC | $35,600 | 0.01% | 50,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $34,288 | 0.01% | 800 | CALL | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $33,645 | 0.01% | 661 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $33,193 | 0.01% | 17,942 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $32,800 | 0.01% | 5,000 | Common | SOLE |
| 03209R103 | AMPH | AMPHASTAR PHARMACEUTICALS IN | $30,737 | 0.01% | 700 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $29,500 | 0.01% | 2,000 | Common | SOLE |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $29,016 | 0.01% | 7,200 | Common | SOLE |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $28,439 | 0.01% | 26,829 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $27,888 | 0.01% | 5,600 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $27,500 | 0.01% | 5,000 | Common | SOLE |
| G97822103 | PRGO | PERRIGO CO PLC | $25,752 | 0.01% | 800 | Common | SOLE |
| 62886E108 | VYX | NCR VOYIX CORPORATION | $25,260 | 0.01% | 2,000 | Common | SOLE |
| 29446K106 | EQ | EQUILLIUM INC | $23,100 | 0.01% | 10,000 | CALL | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $22,520 | 0.01% | 1,000 | Common | SOLE |
| 68236P206 | GTU | ONCTERNAL THERAPEUTICS INC | $22,248 | 0.01% | 2,472 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $20,208 | 0.00% | 10,206 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $19,988 | 0.00% | 1,900 | Common | SOLE |
| 63001N106 | NATL | NCR ATLEOS CORPORATION | $19,750 | 0.00% | 1,000 | Common | SOLE |
| 00972D105 | AKBA | AKEBIA THERAPEUTICS INC | $17,751 | 0.00% | 9,700 | PUT | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $17,160 | 0.00% | 600 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $17,000 | 0.00% | 10,000 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $13,550 | 0.00% | 200 | Common | SOLE |
| 85814R107 | SPLP | STEEL PARTNERS HLDGS L P | $13,521 | 0.00% | 341 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $12,840 | 0.00% | 100 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $11,379 | 0.00% | 5,149 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $10,938 | 0.00% | 200 | Common | SOLE |
| 37962G128 | — | GLOBAL STAR ACQUISITION INC | $10,668 | 0.00% | 118,400 | Common | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $10,020 | 0.00% | 2,000 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $9,245 | 0.00% | 500 | Common | SOLE |
| G89229135 | — | TMT ACQUISITION CORP | $8,982 | 0.00% | 49,900 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $8,670 | 0.00% | 1,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $8,432 | 0.00% | 297 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $8,020 | 0.00% | 2,000 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $7,070 | 0.00% | 450 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $7,000 | 0.00% | 5,000 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $6,400 | 0.00% | 5,000 | Common | SOLE |
| 67190B120 | OAKUR | OAK WOODS ACQUISITION CORP | $6,000 | 0.00% | 30,000 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $5,580 | 0.00% | 38 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $5,350 | 0.00% | 1,000 | Common | SOLE |
| 00654J206 | ADXN | ADDEX THERAPEUTICS LTD | $4,992 | 0.00% | 390 | Common | SOLE |
| 08862E109 | BYND | BEYOND MEAT INC | $4,778 | 0.00% | 577 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $4,274 | 0.00% | 1,295 | Common | SOLE |
| G4740B105 | ICHR | ICHOR HOLDINGS | $4,171 | 0.00% | 108 | Common | SOLE |
| 38942Q202 | CALC | CALCIMEDICA INC | $3,249 | 0.00% | 781 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $2,795 | 0.00% | 601 | Common | SOLE |
| 87424L207 | TLIS | TALIS BIOMEDICAL CORP | $2,625 | 0.00% | 300 | Common | SOLE |
| G3034H141 | EMCRF | EMBRACE CHANGE ACQUISITN COR | $2,524 | 0.00% | 18,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $2,233 | 0.00% | 1,479 | Common | SOLE |
| 37962G110 | — | GLOBAL STAR ACQUISITION INC | $1,956 | 0.00% | 120,000 | Common | SOLE |
| 31561T128 | — | FEUTUNE LIGHT ACQUISITION CO | $1,276 | 0.00% | 15,000 | Common | SOLE |
| 36119D111 | FTIIW | FUTURETECH II ACQUISITION CO | $1,182 | 0.00% | 30,000 | Common | SOLE |
| 27877D112 | — | ECD AUTOMOTIVE DESIGN INC | $818 | 0.00% | 32,596 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $771 | 0.00% | 100 | Common | SOLE |
| 73245B115 | SBCWW | PONO CAP TWO INC | $693 | 0.00% | 19,800 | Common | SOLE |
| 15719Y121 | — | CETUS CAP ACQUISITION CORP | $605 | 0.00% | 4,999 | Common | SOLE |
| 67190B112 | — | OAK WOODS ACQUISITION CORP | $600 | 0.00% | 30,000 | Common | SOLE |
| 31561T110 | — | FEUTUNE LIGHT ACQUISITION CO | $510 | 0.00% | 15,000 | Common | SOLE |
| G3034H125 | EMCWF | EMBRACE CHANGE ACQUISITN COR | $407 | 0.00% | 18,000 | Common | SOLE |
| 35088F115 | FORLW | FOUR LEAF ACQUISITION CORP | $390 | 0.00% | 9,487 | Common | SOLE |
| G0135E126 | AIMWF | AIMFINITY INVESTMENT CORP I | $234 | 0.00% | 18,000 | Common | SOLE |
| 15719Y113 | — | CETUS CAP ACQUISITION CORP | $95 | 0.00% | 5,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.